Thomas Hofer

Person

Zurich, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies binding to STEAP-1
- Patent number 12,129,306
- Issue date Oct 29, 2024
- Hoffman-La Roche Inc.
- Thomas Hofer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agonistic CD28 antigen binding molecules targeting Her2
- Patent number 12,049,515
- Issue date Jul 30, 2024
- HOFFMANN-LA ROCHE INC.
- Stephan Gasser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific HER2 antibodies and methods of use
- Patent number 11,787,873
- Issue date Oct 17, 2023
- HOFFMANN-LA ROCHE INC.
- Rebecca Croasdale-Wood
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies binding to STEAP-1
- Patent number 11,685,790
- Issue date Jun 27, 2023
- HOFFMANN-LA ROCHE INC.
- Thomas Hofer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibody molecules binding to CD3 and TYRP-1
- Patent number 11,672,858
- Issue date Jun 13, 2023
- HOFFMANN-LA ROCHE INC.
- Anne Freimoser-Grundschober
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor-targeted agonistic CD28 antigen binding molecules
- Patent number 11,608,376
- Issue date Mar 21, 2023
- HOFFMANN-LA ROCHE INC.
- Guy Georges
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antibody molecules binding to CD3 and EGFRvIII
- Patent number 11,591,397
- Issue date Feb 28, 2023
- HOFFMANN-LA ROCHE INC.
- Anne Freimoser-Grundschober
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies binding to STEAP-1
- Patent number 11,180,571
- Issue date Nov 23, 2021
- HOFFMANN-LA ROCHE INC.
- Thomas Hofer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunoconjugates
- Patent number 11,130,822
- Issue date Sep 28, 2021
- Roche Glycart AG
- Oliver Ast
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mutant interleukin-2 polypeptides
- Patent number 11,111,312
- Issue date Sep 7, 2021
- Roche Glycart AG
- Oliver Ast
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ASPGR antibodies and uses thereof
- Patent number 10,975,151
- Issue date Apr 13, 2021
- ROCHE GLYCART AG
- Thomas Hofer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific T cell activating antigen binding molecules
- Patent number 10,781,258
- Issue date Sep 22, 2020
- Roche Glycart AG
- Marina Bacac
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific T cell activating antigen binding molecules
- Patent number 10,781,257
- Issue date Sep 22, 2020
- Roche Glyeart AG
- Marina Bacac
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific HER2 antibodies and methods of use
- Patent number 10,584,178
- Issue date Mar 10, 2020
- HOFFMANN-LA ROCHE INC.
- Rebecca Croasdale-Wood
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mutant interleukin-2 polypeptides
- Patent number 10,323,098
- Issue date Jun 18, 2019
- Roche GlycArt AG
- Oliver Ast
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoconjugates
- Patent number 10,316,104
- Issue date Jun 11, 2019
- Roche Glycart AG
- Oliver Ast
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunoconjugates
- Patent number 10,202,464
- Issue date Feb 12, 2019
- Roche Glycart AG
- Oliver Ast
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mutant interleukin-2 polypeptides
- Patent number 10,184,009
- Issue date Jan 22, 2019
- Roche Glycart AG
- Oliver Ast
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific T cell activating antigen binding molecules
- Patent number 10,155,815
- Issue date Dec 18, 2018
- Roche Glycart AG
- Marina Bacac
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ASPGR antibodies and uses thereof
- Patent number 10,087,254
- Issue date Oct 2, 2018
- Roche Glycart AG
- Thomas Hofer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ASGPR antibodies and uses thereof
- Patent number 9,771,427
- Issue date Sep 26, 2017
- Roche Glycart AG
- Thomas Hofer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoconjugates
- Patent number 9,447,159
- Issue date Sep 20, 2016
- Roche Glycart AG
- Oliver Ast
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mutant interleukin-2 polypeptides
- Patent number 9,266,938
- Issue date Feb 23, 2016
- Roche Glycart AG
- Oliver Ast
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CEA antibodies
- Patent number 9,206,260
- Issue date Dec 8, 2015
- Roche Glycart AG
- Thomas U. Hofer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies to carcinoembryonic antigen (CEA), methods of making sam...
- Patent number 9,068,008
- Issue date Jun 30, 2015
- Roche GlycArt AG
- Ekkehard Mössner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selenocysteine mediated hybrid antibody molecules
- Patent number 8,916,159
- Issue date Dec 23, 2014
- The United States of America, as represented by the Secretary, Department of...
- Christoph Rader
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Anti-CEA antibodies
- Patent number 8,642,742
- Issue date Feb 4, 2014
- Roche Glycart AG
- Thomas U. Hofer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING HER2
- Publication number 20250059298
- Publication date Feb 20, 2025
- HOFFMANN-LA ROCHE INC.
- Stephan GASSER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING EPCAM
- Publication number 20240368309
- Publication date Nov 7, 2024
- HOFFMANN-LA ROCHE INC.
- Stephan GASSER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES BINDING TO STEAP-1
- Publication number 20240279355
- Publication date Aug 22, 2024
- HOFFMANN-LA ROCHE INC.
- Thomas HOFER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PH-DEPENDENT MUTANT INTERLEUKIN-2 POLYPEPTIDES
- Publication number 20240092853
- Publication date Mar 21, 2024
- HOFFMANN-LA ROCHE INC.
- Lorenzo DEHO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES BINDING TO CD3
- Publication number 20240042022
- Publication date Feb 8, 2024
- HOFFMANN-LA ROCHE INC.
- Anne FREIMOSER-GRUNDSCHOBER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNE ACTIVATING Fc DOMAIN BINDING MOLECULES
- Publication number 20240043535
- Publication date Feb 8, 2024
- HOFFMANN-LA ROCHE INC.
- Maria Amann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES BINDING TO CD3 AND PLAP
- Publication number 20240018240
- Publication date Jan 18, 2024
- HOFFMANN-LA ROCHE INC.
- Ali Bransi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD3/ANTI-CD28 BISPECIFIC ANTIGEN BINDING MOLECULES
- Publication number 20230416366
- Publication date Dec 28, 2023
- HOFFMANN-LA ROCHE INC.
- Peter BRUENKER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TUMOR-TARGETED AGONISTIC CD28 ANTIGEN BINDING MOLECULES
- Publication number 20230416365
- Publication date Dec 28, 2023
- HOFFMANN-LA ROCHE INC.
- Guy GEORGES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CEA ANTIBODIES
- Publication number 20230365711
- Publication date Nov 16, 2023
- Roche Glycart AG
- Thomas U. Hofer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-HUMAN CD19 ANTIBODIES WITH HIGH AFFINITY
- Publication number 20230312710
- Publication date Oct 5, 2023
- HOFFMANN-LA ROCHE INC.
- Thomas Hofer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEASE-ACTIVATED T CELL BISPECIFIC ANTIBODIES
- Publication number 20230287145
- Publication date Sep 14, 2023
- HOFFMANN-LA ROCHE INC.
- Peter BRUENKER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES BINDING TO CD3
- Publication number 20230277662
- Publication date Sep 7, 2023
- HOFFMANN-LA ROCHE INC.
- Anne FREIMOSER-GRUNDSCHOBER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-HLA-G ANTIBODIES AND USE THEREOF
- Publication number 20230159642
- Publication date May 25, 2023
- HOFFMANN-LA ROCHE INC.
- Alexander Bujotzek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20230076791
- Publication date Mar 9, 2023
- Roche Glycart AG
- Marina BACAC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION OF AN ANTIBODY BINDING CEA AND 4-1BBL
- Publication number 20220267464
- Publication date Aug 25, 2022
- HOFFMANN-LA ROCHE INC.
- Claudia Ferrara Koller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL IMMUNOCONJUGATES
- Publication number 20220242971
- Publication date Aug 4, 2022
- Roche Glycart AG
- Oliver Ast
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-HLA-G antibodies and use thereof
- Publication number 20220213199
- Publication date Jul 7, 2022
- HOFFMANN-LA ROCHE INC.
- Alexander Bujotzek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20220064296
- Publication date Mar 3, 2022
- Roche Glycart AG
- Marina BACAC
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES BINDING TO STEAP-1
- Publication number 20220041747
- Publication date Feb 10, 2022
- HOFFMANN-LA ROCHE INC.
- Thomas HOFER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING HER2
- Publication number 20220017637
- Publication date Jan 20, 2022
- HOFFMANN-LA ROCHE INC.
- Stephan GASSER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES BINDING TO CD3
- Publication number 20220010015
- Publication date Jan 13, 2022
- HOFFMANN-LA ROCHE INC.
- Alejandro CARPY GUTIERREZ CIRLOS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CEA ANTIBODIES
- Publication number 20220002441
- Publication date Jan 6, 2022
- Roche Glycart AG
- Thomas U. Hofer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES BINDING TO CD3
- Publication number 20210403562
- Publication date Dec 30, 2021
- HOFFMANN-LA ROCHE INC.
- Anne FREIMOSER-GRUNDSCHOBER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ASPGR ANTIBODIES AND USES THEREOF
- Publication number 20210324085
- Publication date Oct 21, 2021
- Roche Glycart AG
- Thomas Hofer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20210253703
- Publication date Aug 19, 2021
- Roche Glycart AG
- Marina BACAC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20210253704
- Publication date Aug 19, 2021
- Roche Glycart AG
- Marina Bacac
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20210101979
- Publication date Apr 8, 2021
- Roche Glycart AG
- Marina BACAC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABILIZED IMMUNOGLOBULIN DOMAINS
- Publication number 20210054021
- Publication date Feb 25, 2021
- HOFFMANN-LA ROCHE INC.
- Laura Deak Codarri
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20200385470
- Publication date Dec 10, 2020
- Roche Glycart AG
- Marina Bacac
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Thomas Hofer

Person

Patents Grantslast 30 patents

Antibodies binding to STEAP-1

Agonistic CD28 antigen binding molecules targeting Her2

Bispecific HER2 antibodies and methods of use

Antibodies binding to STEAP-1

Bispecific antibody molecules binding to CD3 and TYRP-1

Tumor-targeted agonistic CD28 antigen binding molecules

Bispecific antibody molecules binding to CD3 and EGFRvIII

Antibodies binding to STEAP-1

Immunoconjugates

Mutant interleukin-2 polypeptides

ASPGR antibodies and uses thereof

Bispecific T cell activating antigen binding molecules

Bispecific T cell activating antigen binding molecules

Bispecific HER2 antibodies and methods of use

Mutant interleukin-2 polypeptides

Immunoconjugates

Immunoconjugates

Mutant interleukin-2 polypeptides

Bispecific T cell activating antigen binding molecules

ASPGR antibodies and uses thereof

ASGPR antibodies and uses thereof

Immunoconjugates

Mutant interleukin-2 polypeptides

Anti-CEA antibodies

Antibodies to carcinoembryonic antigen (CEA), methods of making sam...

Selenocysteine mediated hybrid antibody molecules

Anti-CEA antibodies

Patents Applicationslast 30 patents

AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING HER2

AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING EPCAM

ANTIBODIES BINDING TO STEAP-1

PH-DEPENDENT MUTANT INTERLEUKIN-2 POLYPEPTIDES

ANTIBODIES BINDING TO CD3

IMMUNE ACTIVATING Fc DOMAIN BINDING MOLECULES

ANTIBODIES BINDING TO CD3 AND PLAP

ANTI-CD3/ANTI-CD28 BISPECIFIC ANTIGEN BINDING MOLECULES

TUMOR-TARGETED AGONISTIC CD28 ANTIGEN BINDING MOLECULES

ANTI-CEA ANTIBODIES

ANTI-HUMAN CD19 ANTIBODIES WITH HIGH AFFINITY

PROTEASE-ACTIVATED T CELL BISPECIFIC ANTIBODIES

ANTIBODIES BINDING TO CD3

ANTI-HLA-G ANTIBODIES AND USE THEREOF

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

FUSION OF AN ANTIBODY BINDING CEA AND 4-1BBL

NOVEL IMMUNOCONJUGATES

Anti-HLA-G antibodies and use thereof

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

ANTIBODIES BINDING TO STEAP-1

AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING HER2

ANTIBODIES BINDING TO CD3

ANTI-CEA ANTIBODIES

ANTIBODIES BINDING TO CD3

ASPGR ANTIBODIES AND USES THEREOF

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

STABILIZED IMMUNOGLOBULIN DOMAINS

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES